Top Markets
Coin of the day
Accelerate Diagnostics, Inc. Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc.

AXDX
Peringkat dalam Saham #40437
Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in... Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in solutions for the rapid diagnosis of critical infections, with operations spanning the United States, Europe, and the Middle East. The company's primary offering is the Accelerate Pheno system, an advanced in vitro diagnostic platform. Paired with its dedicated test kit, the Accelerate PhenoTest, this system facilitates quick identification and antimicrobial susceptibility testing (AST) for pathogens responsible for severe or healthcare-associated infections, encompassing both Gram-positive and Gram-negative organisms. The PhenoTest is specifically designed to yield crucial ID and AST results for patients suspected of bacteremia or fungemia – life-threatening conditions marked by high morbidity and mortality risks. Established in 1982, the company initially operated as Accelr8 Technology Corporation before adopting its current name, Accelerate Diagnostics, Inc., in December 2012. Its corporate headquarters are located in Tucson, Arizona.
Harga Saham
$0.01005
Terakhir disinkronkan: 2025-06-09
Kapitalisasi Pasar
$146.42K
Perubahan (1 hari)
-28.21%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Accelerate Diagnostics, Inc. (AXDX)

Kategori

EPS untuk Accelerate Diagnostics, Inc. (AXDX)
EPS per 2026 TTM: 0
Menurut laporan keuangan terbaru dan harga saham Accelerate Diagnostics, Inc., EPS perusahaan saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki EPS sebesar 0 sama dengan EPS tahun 2026 sebesar 0.
Riwayat EPS untuk Accelerate Diagnostics, Inc. dari 2026 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
Tidak cukup data untuk tanggal yang disediakan.
EPS untuk perusahaan sejenis atau pesaing